3,841 Total Views
Diagnostics
Working towards
a Drug-Free India
Diagnostics is a primary and an elemental product section of Ragok Medicare. Ragok Medicare is an exclusive partner from India for its diagnostic/Medical devices (DOA Products) of Wondfo Biotech (One of the World’s leading manufacturer of Medical Devices).
At Ragok Medicare we specialize in Drug of Abuse Testing Kits (DOA) providing customize drug diagnostic solutions keeping quality core and customer health at its utmost priority.
What is DOA?
Drug-of-Abuse kits (DOA) are diagnostic equipment which are used to detect the presence of psychoactive substances (Narcotics substances) in a human body through Urine.
These drugs are detected accurately through an advanced testing technology platform called “Colloidal Gold ”.
The Prospective psychoactive substances consumed in India & which can be detected are as follows.
- Amphetamine (AMP)
- Methamphetamine (MET/mAMP)
- Barbiturates (BAR)
- Buprenorphine / Norbuprenorphine(BUP)
- Benzodizipine (BZO)
- Cocaine(COC)
- Morphine (MOP)
- Methadone (MTD)
- Oxycodone (OXY)
- Phencyclidine(PCP)
- PRopoxyphene(PPX)
- Marijuana/Hashish(THC)
- MDMA/Ecstasy
- Cotinine (COT)
- Opiate(OPI)
- Tramadol(TRA)
Product Range
*All our DOA Products are CLIA Waived / Certified
Single Panel (Dip Card / Cassette)
One Step DOA (Single Item) Urine Test Panels/Cassettes are intended for the qualitative detection of DOA markers and their principal metabolites in human urine at specified cut-off level. The Multi Drug Test containing a fentanyl test strip is not for sale in Canada.
How To Use?
Technology
Colloidal Gold Platform
- The most developed technology platform.
- Easy to use, require no equipment to process the sample or read the result.
- Wide range of applications, including detecting acute infectious disease, drug of abuse, etc.
Why Choose Us?
Product Certification – Recognition Organization
